<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03164421</url>
  </required_header>
  <id_info>
    <org_study_id>ZUH 7</org_study_id>
    <nct_id>NCT03164421</nct_id>
  </id_info>
  <brief_title>N-Acetylcysteine and L-carnitine in Pcos</brief_title>
  <official_title>N-Acetylcysteine Versus L-carnitine in Clomiphene Citrate Resistant Pcos Women. a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zagazig University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zagazig University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      N-Acetylcysteine and L-carnitine were used in pcos patients
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      N-Acetylcysteine was compared to L-carnitine in clomiphene citrate in Pcos women to detect
      the hormonal and metabolic effect
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2017</start_date>
  <completion_date type="Anticipated">May 2018</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>pregnancy rate</measure>
    <time_frame>3 momths</time_frame>
    <description>number of women with clinical pregnancy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>ovulation rate</measure>
    <time_frame>3 momths</time_frame>
    <description>number of women with follicle &gt;18mm.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>abortion rate</measure>
    <time_frame>3 momths</time_frame>
    <description>number of women with abortions</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>PCOS</condition>
  <arm_group>
    <arm_group_label>N-Acetylcysteine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>N-Acetylcysteine used by clomiphene resistant pcos women</description>
  </arm_group>
  <arm_group>
    <arm_group_label>L-carnitine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>L-carnitine used by clomiphene resistant pcos women</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>N-Acetylcysteine</intervention_name>
    <description>N-Acetylcysteine in clomiphene resistant pcos women</description>
    <arm_group_label>N-Acetylcysteine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>L-carnitine</intervention_name>
    <description>L-carnitine in clomiphene resistant pcos women</description>
    <arm_group_label>L-carnitine</arm_group_label>
    <other_name>motova plus</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  pco

          -  infertile

        Exclusion Criteria:

          -  no medical disorders

          -  no hormonal treatment in the previous 3 months
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ibrahim A EL sharkwy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>FACULTY OF MEDICINE ,ZAGAZIG UNIVERSITY</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>ibrahim A EL sharkwy, MD</last_name>
    <phone>00966554818576</phone>
    <email>ibrahimsharkwy@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>mohamed L el sayeed, MD</last_name>
    <phone>00201222442467</phone>
    <email>drmohamedlotfy@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Zagazig University</name>
      <address>
        <city>Zagazig</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 21, 2017</study_first_submitted>
  <study_first_submitted_qc>May 22, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 23, 2017</study_first_posted>
  <last_update_submitted>May 19, 2018</last_update_submitted>
  <last_update_submitted_qc>May 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 22, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Zagazig University</investigator_affiliation>
    <investigator_full_name>IBRAHIM ABD ELGAFOR</investigator_full_name>
    <investigator_title>assistant professor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetylcysteine</mesh_term>
    <mesh_term>N-monoacetylcystine</mesh_term>
    <mesh_term>Clomiphene</mesh_term>
    <mesh_term>Enclomiphene</mesh_term>
    <mesh_term>Zuclomiphene</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>the collected data willbe available within 6 months</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

